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PURPOSE. To determine the effects of COCH transgene expres-
sion on cultured human trabecular meshwork (HTM) cell mor-
phology and on outflow facility (OF) in monkey organ cultured
anterior segments (MOCAS).
METHODS. An adenoviral (Ad) vector expressing both cochlin
(COCH) and green fluorescent protein (GFP) (AdCOCHGFP) or
GFP alone (AdGFP) was used to transduce cultured HTM cells
(multiplicity of transduction, 2.8 and 28). COCH transgene
expression in transduced HTM cells and the culture medium
was verified by Western blot analysis and immunofluorescence
detection 5 days after transduction. MOCAS were used to test
the effect of Ad vectors (2.8 1010 viral particles per segment)
on OF. The morphology of transduced MOCAS was evaluated
by light microscopy.
RESULTS. Western blot analysis showed a viral vector dose-
dependent expression of cochlin in transduced cells and the
culture medium. There was no notable morphologic change in
transduced cells. In MOCAS, cochlin expression was detect-
able in the medium by 3 days after transduction. A 35% de-
crease in OF in AdCOCHGFP-transduced MOCAS was detected
after 3 days, decreasing by 76% after 12 days when compared
to control segments injected with AdGFP. Anterior segment
pressure (ASP) more than doubled (P  0.05) in segments
injected with AdCOCHGFP at 12 days after transduction. Light
microscopy revealed normal angle structures in transduced
segments.
CONCLUSIONS. Ad vector delivery of the COCH transgene re-
sulted in cochlin expression in HTM cells and MOCAS. Cochlin
expression was effective in decreasing OF and increasing ASP
in MOCAS, suggesting possible involvement of cochlin in IOP
elevation in vivo. COCH gene delivery has potential for use in
developing a glaucoma model. (Invest Ophthalmol Vis Sci.
2010;51:2060–2066) DOI:10.1167/iovs.09-4521
Glaucomas are a group of irreversible blinding eye diseases.The projected number of people affected with glaucoma
worldwide in 2010 is approximately 60.5 million.1 Primary
open-angle glaucoma (POAG) is the most common form of
glaucoma, where intraocular pressure (IOP) is a causal risk
factor for optic neuropathy and lowering IOP has beneficial
effects.2–5 Elevation in IOP occurs because of an imbalance
between aqueous humor production and outflow.6 This imbal-
ance occurs in part in glaucomatous eyes because of an in-
creased resistance to aqueous humor outflow, particularly
within the trabecular meshwork (TM) of the anterior segment.
Changes within the extracellular matrix (ECM) of the TM,
especially the increased deposition of ECM proteins, are
thought to contribute to the increased resistance to outflow.7
Cochlin is an ECM protein8 that was identified in human
glaucomatous but not in control TM tissue by proteomic anal-
ysis and was associated with TM protein and mucopolysaccha-
ride deposits.9 It is also expressed in glaucomatous DBA/2J
mice but not in wild-type (CD1 or C57BL6J) mice.10 Structur-
ally, cochlin contains a signal peptide for secretion into the
ECM,8 a factor C homology (FCH) domain, and two von Wil-
lebrand factor A-like (vWFA) domains.11,12 It undergoes mul-
timerization in response to applied shear stress,9 which is a
property of the vWF domain.13 Cochlin deposits are also found
in the inner ear where it is associated with progressive hearing
loss disorder DFNA9.8,14 Glaucoma and autosomal dominant
nonsyndromic sensorineural hearing loss (DFNA9) both are
late-onset and progressive diseases and are also associated with
local changes in fluid flow: glaucoma with fluid flow in the TM
and DFNA9 with fluid flow in the inner ear.15,16
In the TM, cochlin is secreted into the ECM.15 Its expres-
sion in anterior segment organ culture models is increased after
TGF2-treatment17 and is associated with anterior segment
pressure (ASP) elevation and outflow facility (OF) reduction.
Whether cochlin overexpression alone is sufficient to elevate
IOP (in the anterior segment culture context: ASP) or is a
consequence of other TGF2-induced changes relevant to IOP
elevation is not yet known. Injection of siRNA against cochlin
in the New Zealand White rabbits decreases IOP by approxi-
mately 25% for 78 hours, suggesting that cochlin expression
can influence IOP (Graham FL, et al. IOVS 2007;48:ARVO
E-Abstract 4808). We have shown that exogenous cochlin also
results in aggregation of isolated primary TM cells.9
From the Departments of 1Ophthalmology and Visual Sciences,
3Pathology and Laboratory Medicine, and 4Medical Microbiology, Uni-
versity of Wisconsin, Madison, Wisconsin; the 2Department of Oph-
thalmology, Institute of Vision Research, Yonsei University College of
Medicine, Seoul, Republic of Korea; and the 5Bascom Palmer Eye
Institute, University of Miami, Miami, Florida.
Supported by National Institutes of Health Grants R01 EY002698,
R01 EY017006, R01 EY016236, P30 EY016665, P51 RR000167, S10
RR019382, P30 EY01480, R03 EY15266, and R01 EY016112; unre-
stricted grants from Research to Prevent Blindness (RPB); an RPB
Career Award (SKB); a faculty research grant 6-2009-0515 from Yonsei
University College of Medicine for 2009 (ESL), and funds from the
Ocular Physiology Research and Education Foundation (PLK).
Submitted for publication August 20, 2009; revised October 28,
2009; accepted November 4, 2009.
Disclosure: E.S. Lee, None; B.T. Gabelt, None; J.A. Faralli, None;
D.M. Peters, None; C.R. Brandt, None; P.L. Kaufman, None; S.K.
Bhattacharya, None
*Each of the following is a corresponding author: Sanjoy K. Bhat-
tacharya, University of Miami, Bascom Palmer Eye Institute, 1638 NW
10th Avenue, 706, Miami, FL 33136; sbhattacharya@med.miami.edu.
Eun Suk Lee, Yonsei University, Department of Ophthalmology and
Visual Science, Sodaemungu Shinchondong, Seoul 120-752, Korea;
eslee.korea@gmail.com.
Glaucoma
Investigative Ophthalmology & Visual Science, April 2010, Vol. 51, No. 4
2060 Copyright © Association for Research in Vision and Ophthalmology
In the present study, we determined whether adenovirus-
mediated expression of cochlin alone is sufficient to alter the
morphology of cultured human trabecular meshwork (HTM)
cells and/or alter ASP and OF in monkey organ cultured ante-
rior segments (MOCAS).
METHODS
Construction of Recombinant Replication-
Deficient Adenoviral Vector Carrying Human
Cochlin and GFP Genes
An adenoviral vector construction system (AdEasy Adenoviral system;
Stratagene, La Jolla, CA) was used. Cochlin (COCH) cDNA (GenBank
accession number AF006740; http://www.ncbi.nlm.nih.gov/Genbank;
provided in the public domain by the National Center for Biotechnol-
ogy Information, Bethesda, MD) was subcloned into the shuttle vector,
pShuttle-CMV, with an influenza virus hemagglutinin (HA) tag fused to
the carboxyl terminus of COCH. This dual-expression vector also con-
tained the gene for GFP downstream from an internal ribosome entry
site (IRES) element, so that COCH and GFP could be expressed from
the same transcript. The resultant pShuttle-COCH was then used to
generate adenoviral recombinants through homologous recombination
with the adenoviral backbone vector, pAdEasy-1, in BJ5183 bacterial
cells (Stratagene). For packaging, the COCH vector DNA was linearized
by digestion with PacI. The linearized DNA was then transfected into
HEK293 cells (Lipofectamine Plus; Invitrogen, Carlsbad, CA) according
to the manufacturer’s instructions. The cultures were transfected at
37°C with 5% CO2 for 3 hours, at which time the medium was replaced
with DMEM with 10% fetal bovine serum (FBS). A separate adenovirus
vector expressing GFP alone (AdGFP) was used as the control. Virus
titers were determined by spectrophotometric absorbance at 260 nm
of viral particles (VPs), as described previously.18
Transduction of HTM Cells
HTM cells were isolated, as previously described.19–21 from a 17-year-
old male donor and a 27-year-old female donor, with no known history
of ocular disease. All experiments were performed with cultures be-
tween passages 5 and 7. The cells were grown to confluence in
low-glucose DMEM (Sigma-Aldrich, St. Louis, MO) containing 15% FBS,
2 mM L-glutamine, 1% amphotericin B (Mediatech, Herndon, VA),
0.05% gentamicin (Mediatech), and 1 ng/mL FGF-2 (Peprotech, Rocky
Hill, NJ). Cultures were maintained for one additional week after
confluence, after which time FGF-2 was removed from the medium
and the serum level reduced to 10%. All the cultures were then used
within 1 to 3 days and exhibited a stable endothelial-like morphology
at the time when they were transduced with AdGFP or AdCOCHGFP.
The cultures were transduced at multiplicities of transduction (MOT)
of 2.8 and 28 in DMEM containing 10% FBS and 2 mM L-glutamine.
Controls were nontransduced cells that were incubated with fresh
DMEM containing 10% FBS.
Morphology of HTM Cell Cultures Transduced
with Adenovirus Vectors
Light microscope images of transduced cultures were captured with an
inverted microscope (Axiovert 200; Carl Zeiss Meditec, Inc., Thorn-
wood, NY) equipped with a high-resolution color camera (AxioCam;
Carl Zeiss Meditec, Inc.), on the day of and 5 days after transduction All
images were processed with the system software (Axiovision 4.2; Carl
Zeiss Meditec, Inc.).
Western Blot Analysis
To confirm expression of the cochlin protein, both HTM cell lysates
and medium were collected 5 days after transduction. The HA-cochlin
in the medium was isolated by immunoprecipitation with anti-HA
Sepharose (Covance, Emeryville, CA), collected by centrifugation, and
resuspended in Laemmli sample buffer22 containing 2% -mercapto-
ethanol. Cell lysates were prepared by scraping the cells from culture
dishes into 1 phosphate-buffered saline (PBS). Microscopic examina-
tion confirmed that 99.99% of the cells were removed from the
dishes. The cells were then pelleted by centrifugation at 2500 rpm for
3 minutes and resuspended in sample buffer containing 2% -mercap-
toethanol. The cells were lysed by sonication for 12 cycles on ice. Both
cell lysates and medium were boiled for 5 minutes and were electro-
phoresed in 10% SDS-polyacrylamide gels. The proteins were then
electrophoretically transferred to nitrocellulose, blocked with 5% non-
fat dry milk in 1 buffer (Genius buffer I; 100 mMmaleic acid, 150 mM
NaCl [pH 7.5]; Techne, Princeton, NJ) with 0.3% vol/vol Tween-20 and
probed with polyclonal anti-cochlin antibody (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA). The membrane was washed and incubated with
secondary donkey anti-goat IgG conjugated with horseradish peroxi-
dase (HRP; Santa Cruz Biotechnology) and then developed with the
enhanced chemiluminescence (ECL) system (Amersham Biosciences,
Piscataway, NJ), according to the manufacturer’s instructions and ex-
posed to x-ray film.
Cochlin expression in the medium from MOCAS was also analyzed
by Western blot analysis. For these studies medium was collected
overnight on days 0, 3, 6, 9, and 12 (one sample was collected at 11
days) and in some cases 24 days after transduction. All medium/
perfusate was removed from the dish on the day before the collection
day. On the designated collection day, the medium was aspirated into
a syringe, transferred to a tube, and frozen at 70°C until it was
analyzed. The average SEM duration of the medium collection period
was 24  2 hours. The HA-cochlin in medium was isolated by immu-
noprecipitation, as described for the cell culture medium.
ASP and OF in MOCAS
Eyes from rhesus monkeys (Macaca mulatta) and cynomolgus mon-
keys (Macaca fascicularis) from either the Wisconsin National Primate
Research Center or Dr. Kaufman’s colony at the University of Wiscon-
sin School of Medicine and Public Health, which were being euthana-
tized for other protocols (adhering to the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research) were obtained fresh
and placed in organ culture, usually less than 2 hours after enucleation.
The anterior segments were prepared for organ culture as described in
detail in a previous report.23 Briefly, the eyes were bisected at the
equator. The lens, iris, and ciliary body were removed from the ante-
rior segment. The anterior segment was then mounted in the organ
culture dish and secured with tissue glue and a plastic ring lined with
aquarium silicone. Medium was infused at a constant rate of 2.5
L/min except when OF was being measured. Baseline (BL) OF was
measured after overnight equilibration by using the two-level constant
pressure perfusion technique.24 Briefly, fluid flow from an external
reservoir was measured for approximately 1 hour, alternating every 4
minutes between two different pressures 10 mm Hg apart. OF was
calculated as the change in flow divided by the change in pressure and
sequentially averaged. Medium infusion continued at a constant rate of
2.5 L/min when OF was not being measured. ASP in MOCAS was
monitored (Isotec transducers/HSE Tam-D amplifier; Harvard Appara-
tus, Holliston, MA) and recorded every 15 minutes throughout the
experiment, except at those times when infusion was temporarily
stopped to take OF measurements or to replenish the medium in the
infusion syringe (roughly once every 72 hours). It is important to note
that we have compared the change after adjusting BL values; therefore
the differences in BL between test and control groups are not expected
to affect the measurable outcome. Anterior segments were injected via
the inflow port with 80 L containing 2.8  1010 VPs of AdCOCHGFP,
whereas the contralateral anterior segments received the same dose of
AdGFP. Studies were usually terminated after 12 days but in some cases
were maintained for up to 24 days.
GFP Expression and Cochlin Localization in the
TM of MOCAS
At the endpoint of the cochlin OF studies, all MOCAS were perfused at
8 mm Hg with 5 mL of 4% paraformaldehyde for 30 minutes, cut into
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quadrants or eighths, and then immersed in 4% paraformaldehyde. A
piece from each quadrant of each MOCAS was examined by fluores-
cence microscopy for GFP fluorescence in the outflow pathways and
then embedded in paraffin, and 5-m sections were prepared. To
assess the integrity of angle structure and Schlemm’s canal, we stained
sections with hematoxylin and eosin (H&E). To localize cochlin in
transduced segments, sections were mounted on glass slides, deparaf-
finized, and blocked in 0.2% bovine serum albumin (BSA; Sigma-Al-
drich)/PBS after previously described procedures.9 Sections were la-
beled with a 1:50 dilution of goat polyclonal anti-cochlin antibody15 for
1 hour at room temperature followed by Alexa 594-conjugated donkey
anti-goat IgG (1:300 dilution, 1 hour; Invitrogen). Sections were also
labeled with Hoechst 33342 (cat. no. H1399; Invitrogen) to visualize
nuclei.
Data Analysis
ASP and OF data are expressed as the mean  SEM and were analyzed
by the two-tailed paired t-test for ratios compared to 1.0 (OF) or for
differences compared with 0.0 (ASP). For data analysis, only segments
demonstrating GFP expression and BL OF of less than 0.75 L/min/mm
Hg were included. Mean ASP SEM for the designated time points was
usually calculated by averaging 40 consecutive pressure measurements
at least 2 hours after any system stoppage. For unpaired group analysis,
all segments were analyzed by the two-tailed unpaired t-test. For paired
group analysis, only contralateral anterior segments from a given mon-
key were compared by the two-tailed paired t-test (all analyses: SPSS
11.5; SPSS, Chicago, IL). AdCOCHGFP and AdGFP transduced segments
were compared with each other after normalization for BL differences.
AdCOCHGFP segments were defined as responders when an OF de-
crease of at least 50% was observed at 12 days after AdCOCHGFP
transduction after normalization for BL. Repeated-measures ANOVA
(RMANOVA) was performed to evaluate the time-course of OF re-
sponses for AdCOCHGFP and AdGFP.
RESULTS
COCH Transgene Expression in Cultured
HTM Cells
HTM cells transduced with AdCOCHGFP at either MOT 2.8 or
28 did not show any morphologic changes compared with
nontransduced or AdGFP transduced control cells transduced
at MOT 28 (Figs. 1A–D). The morphology of AdGFP-transduced
cells at the lower MOT (2.8) was also unchanged compared
with nontransduced cells (data not shown). Transduction of
HTM cells by AdGFP or AdCOCHGFP was confirmed by GFP
expression (Figs. 1E–H). Western blot analysis also confirmed
the expression of cochlin and showed a viral vector dose-
dependent expression of a60- to 66-kDa protein correspond-
ing to cochlin 5 days after transduction in AdCOCHGFP-trans-
duced cells and medium but not in nontransduced or AdGFP-
transduced cells or medium (Fig. 2). Lysates from cells
transduced with AdCOCHGFP also showed a 40-kDa isoform
band of cochlin.8,25 Lower molecular weight bands in the
AdCOCHGFP transduced cells (shown) and medium (not
shown) detected by anti-cochlin antibody may represent coch-
lin degradation products.8,26
Cochlin Expression in MOCAS
At the conclusion of the experiment, GFP fluorescence in the
MOCAS was examined (Fig. 3) to confirm the efficient trans-
duction by either AdCOCHGFP or AdGFP. Although most GFP
expression occurred in the TM (Fig. 3), occasional fluores-
cence was also visible in the corneal endothelium and the
remnant of the ciliary body. Cochlin expression was also con-
firmed by using anti-cochlin staining in paired anterior seg-
ments transduced with AdGFP (Figs. 3A–D) or AdCOCHGFP
(Figs. 3E–H). The paired control segments, transduced with
AdGFP, showed prominent GFP expression (Fig. 3B) but
failed to demonstrate any positive staining for cochlin (Fig.
3C). In contrast, the TM of anterior segments transduced with
AdCOCHGFP demonstrated strong, positive staining for coch-
lin (Fig. 3G) in areas showing GFP expression (Fig. 3F), indi-
cating robust cochlin expression.
Tissue cellularity was similar for segments transduced with
AdGFP or AdCOCHGFP (Figs. 3A, 3E) as demonstrated by the
presence of cell nuclei (Figs. 3D, 3H), an intact Schlemm’s
canal and organized trabecular beams in both AdGFP and
AdCOCHGFP transduced segments (Fig 3).
Transduction of the COCH gene with adenoviral vectors
also resulted in the secretion of the expressed cochlin into the
medium (Fig. 4). Peak cochlin secretion into the medium was
FIGURE 1. Human trabecular meshwork cell morphology and GFP
expression 5 days after transduction with adenoviral vectors. No alter-
ation in trabecular meshwork cell morphology was apparent after
transduction with AdCOCHGFP or AdGFP (A–D). GFP expression was
examined by inverted microscopy (E–H). (A, E) Nontransduced con-
trol. (B, D, F, H) AdCOCHGFP transduced at MOTs of 2.8 (B, F) and 28
(D, H). (C, G) AdGFP transduced at MOTs of 28. Bar, 50 m.
FIGURE 2. Western blot analysis for cochlin demonstrating viral vec-
tor dose-dependent cochlin expression in AdCOCHGFP-transduced
cells. Nontransduced cells served as the control. The cells were trans-
duced with either AdGFP or AdCOCHGFP at MOTs of 28 or 2.8, as
indicated. Cell lysates and medium were collected 5 days after trans-
duction. (A) Medium and (B) cell lysates probed with anti-cochlin
antibody after transfer to a PVDF membrane.
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detected 3 days after transduction which was the earliest time
point examined. Cochlin expression persisted for up to 24 days
(data not shown) after transduction, although the level of
expression in the medium was weaker than that observed at 3
days. Cochlin was absent in medium collected before transduc-
tion or in medium from AdGFP-transduced segments (Fig. 4).
Effect of Cochlin Expression on OF in MOCAS
Only segments that had normal BL OF in the range of 0.20 to
0.75 L/min/mm Hg were considered. Nine AdCOCHGFP- and
seven AdGFP-transduced segments originating from nine rhe-
sus and two cynomolgus monkeys were included for data
analysis. Of these 16 segments, there were five in vivo con-
tralateral pairs. Table 1 shows the effect of Ad-transduced
expression of cochlin in MOCAS on OF. Unpaired and paired
analysis showed that BL OF for AdCOCHGFP (0.44  0.04 and
0.42  0.05) was lower than that of AdGFP (0.52  0.05 and
0.56  0.05) segments (both P  0.01). The analysis showed
that a reduction in OF in AdCOCHGFP was detected 3 days
after transduction (35% decrease, unpaired, P  0.001) com-
pared with AdGFP segments after a correction for BL facility.
OF decreased further over the 12-day duration of the study
(76% decrease, unpaired, P 0.001). A similar trend was found
when paired segments were analyzed. In this instance, a 55%
reduction occurred at 12 days after transduction (P  0.05).
When only responder AdCOCHGFP segments were included,
OF was decreased by 83% and 68%, for unpaired (n  7) and
paired analysis (n  4), respectively, 12 days after transduc-
tion. Time course analysis for the OF response after transduc-
tion revealed that, whereas OF was not changed in AdGFP-
transduced segments, OF in AdCOCHGFP-transduced segments
was significantly decreased 9 to 12 days after transduction
when compared to BL (RMANOVA, unpaired segments, Fig. 5,
P  0.001; paired segments, data not shown, P  0.022).
Change in ASP was evaluated in a similar manner. Although
BL ASP before adenovirus injection was not significantly differ-
ent between AdGFP-and AdCOCHGFP-transduced segments,
ASP posttransduction in AdCOCHGFP-transduced segments
was elevated by approximately 140% to 170% (unpaired and
paired, P  0.05) by day 12 when compared with AdGFP-
transduced segments after correction for BL. There was no
detectable ASP increase in two segments (Fig. 6), and so the
results were also evaluated using only responder segments.
When the responder segments were evaluated, the magnitude
of ASP increase in AdCOCHGFP-injected segments was approx-
imately 150% to 210% (unpaired and paired, P  0.05). The
two pairs of segments that did not demonstrate any ASP ele-
vation after transduction (Fig. 6) had detectable levels of co-
chlin in the tissue and medium.
DISCUSSION
This study demonstrated, for the first time, that cochlin expres-
sion alone results in an OF decrease and subsequent ASP
increase. Previously,17 we demonstrated that TGF2-induced
ASP elevation was associated with an increase in cochlin se-
cretion into the medium and expression in the tissue of mon-
key and pig organ-cultured anterior segments treated with
TGF2. Since TGF2 has been shown to increase TM ECM
protein production leading to ECM remodeling, previously
reported reductions in the outflow of aqueous humor and
elevation in ASP may be attributable to the production of these
other proteins.27–29 Whether the increase in IOP in human and
DBA/2J mice9 as well as in the organ culture systems is due
solely to the overexpression of cochlin or interactions between
cochlin and other proteins in the ECM is still unknown.
The magnitude and time of onset of the ASP change in
seven responders was quite variable despite the fact that all
segments in this study were injected with a fixed amount of
virus (2.8  1010 VPs/segment; Fig. 6) and cochlin was con-
sistently expressed (data not shown). In five of the nine MO-
CAS that showed GFP and cochlin expression, the ASP increase
was gradual, whereas two responders (segments 1 and 3, Fig.
6) showed a decrease in OF with subsequent ASP increase after
day 9. The gradual change in ASP suggests that the effect may
be due to the time it took to reach a critical level of cochlin
expression in the TM. This notion would be consistent with
the fact that the maximum secretion of cochlin into the me-
dium occurred at 3 days after AdCOCHGFP transduction.
Alternatively, the variability in the responses may be be-
cause the efficiency of vector delivery and transduction in
organ culture and/or the tissue susceptibility varied between
segments. Several factors govern gene expression from a viral
vector, including local fluid dynamics at the time of injection
and intrinsic properties of the host tissue, not all of which are
FIGURE 3. Cochlin localization in
AdCOCHGFP-transducedMOCAS.(A–D)
AdGFP-transduced segment. (E–H)
AdCOCHGFP-transduced segment. The
hematoxylin-eosin–stained anterior eye
segments (H&E) are shown to demon-
strate cellularity. Paraffin-embedded sec-
tions (5 m) showed GFP expression
(green channel; B, F) and were labeled
for cochlin (red channel, Alexa Fluor; C,
G). Merged images including DAPI-
stained cell nuclei (blue channel) are
shown in (D) and (H). Note that only
segments transduced with AdCOCHGFP
showed cochlin (G). Bar, 50 m.
FIGURE 4. Western blot analysis demonstrating cochlin secretion into
the medium of AdCOCHGFP-transduced MOCAS. Detection was per-
formed with an antibody specific to cochlin protein after immunopre-
cipitation of the medium by anti-HA Sepharose. AdCOCHGFP- and
AdGFP-transduced MOCAS media were subjected to analysis as indi-
cated.
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well understood. Relatively fresh tissue often appears to pos-
sess greater viral load tolerance and greater expression levels
compared with older tissue as exemplified by comparing dif-
ferent reports.30–34 In one study, approximately 3  1010 VPs
were well tolerated in vivo and showed consistent expression
for more than 2 years,32 while in another study, 108 pfu (1010
VP) caused 100% loss of TM cells in human organ culture.31
The levels of transduction obtained in organ culture with
adenoviral vectors may vary experimentally, and this could be
a factor in the variability of the results observed.
In studies conducted with MOCAS treated with TGF2 as
well as in the current studies of cochlin overexpression, ASP
elevation required some time to develop. However, in both
experiments, the time-dependent reduction in OF was approx-
FIGURE 5. Time-course of OF response normalized to that of BL for
AdCOCHGFP (n  8)- and AdGFP (n  6)-transduced segments. Data
are the mean  SEM. The ratio was significantly changed over time in
the AdCOCHGFP-transduced segments (RMANOVA, P  0.001),
whereas that of the AdGFP-transduced segments was not changed (P
0.05).
FIGURE 6. Change in ASP for individual AdCOCHGFP (n  9)- and
AdGFP (n  7)-treated MOCAS 12 days after transduction (8 days after
transduction in segment 1 and 11 days after transduction in segment
9). Data are expressed as the percentage change in ASP compared with
BL. The mean ratio was subjected to a two-tailed paired t-test; *P 
0.05.
TABLE 1. Effect of Cochlin on Outflow Facility of MOCAS
Unpaired Segments Paired Segments
Outflow Facility
AdCOCHGFP/AdGFP
Outflow Facility
AdCOCHGFP/AdGFPAdCOCHGFP AdGFP AdCOCHGFP AdGFP
All
BL 0.44  0.04 0.52  0.05 0.84  0.11* 0.42  0.05 0.56  0.05 0.75  0.04*
Rx(d3) 0.40  0.06 0.71  0.08 0.57  0.11† 0.36  0.05 0.72  0.10 0.52  0.07*
Rx(d3)/BL 0.91  0.11 1.40  0.15 0.65  0.11† 0.90  0.15 1.33  0.21 0.71  0.11
Rx(d6) 0.35  0.07 0.65  0.14 0.54  0.15† 0.31  0.10 0.62  0.17 0.59  0.18
Rx(d6)/BL 0.81  0.18 1.28  0.25 0.63  0.19† 0.78  0.31 1.17  0.31 0.79  0.24
Rx(d9) 0.27  0.06 0.72  0.21 0.38  0.14† 0.23  0.07 0.69  0.26 0.47  0.17‡
Rx(d9)/BL 0.63  0.15 1.41  0.36 0.45  0.16† 0.55  0.21 1.29  0.45 0.61  0.21
Rx(d12) 0.15  0.04 0.81  0.26 0.19  0.07† 0.16  0.06 0.69  0.28 0.35  0.14*
Rx(d12)/BL 0.37  0.10 1.53  0.46 0.24  0.10† 0.39  0.17 1.30  0.49 0.45  0.16‡
Responder
BL 0.46  0.05 0.58  0.04 0.79  0.11* 0.44  0.06 0.59  0.05 0.73  0.04*
Rx(d3) 0.38  0.07 0.75  0.10 0.51  0.12† 0.33  0.04 0.72  0.13 0.48  0.08*
Rx(d3)/BL 0.81  0.11 1.32  0.20 0.61  0.30† 0.77  0.11 1.24  0.23 0.68  0.14
Rx(d6) 0.28  0.06 0.71  0.19 0.39  0.13† 0.22  0.05 0.62  0.22 0.46  0.17‡
Rx(d6)/BL 0.58  0.09* 1.28  0.35 0.45  0.14* 0.48  0.10 1.10  0.39 0.64  0.24
Rx(d9) 0.21  0.06 0.86  0.28 0.25  0.10† 0.17  0.05 0.73  0.33 0.37  0.17‡
Rx(d9)/BL 0.45  0.11† 1.41  0.37 0.45  0.16† 0.36  0.11 1.31  0.57 0.49  0.22
Rx(d12) 0.12  0.02 0.88  0.31 0.14  0.05† 0.11  0.04 0.75  0.35 0.24  0.11*
Rx(d12)/BL 0.28  0.05 1.62  0.55 0.17  0.06† 0.24  0.08 1.35  0.62 0.32  0.14‡
Data are the mean  SEM. AdCOCHGFP to AdGFP ratio (AdCOCHGFP/AdGFP) was significantly different from 1.0 by the two-tailed,
two-sample t-test for unpaired segments or by the paired t-test for paired segments as indicated. For unpaired segments: all, n  9 for AdCOCHGFP
(8 for day 12); n 7 for AdGFP (6 for day 12); responder, n 7 for AdCOCHGFP; n 5 for AdGFP. For paired segments: all, n 5 (5 contralateral
pairs included in the unpaired 16 segments); responder, n 4 (5 contralateral pairs included in the unpaired 12 responder segments). BL, baseline;
Rx, treatment with adenovirus as indicated.
* P  0.01.
† P  0.001.
‡ P  0.05.
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imately 40% after 5 to 9 days. Cochlin induction by TGF2 was
slower, suggesting that more complex interactions may be
involved in the ASP elevation compared with that after COCH
transduction alone. In contrast, OF gradually increased with
time in control AdGFP-transduced MOCAS. There is normally a
gradual increase in OF and a decrease in ASP over several days
that is probably due to washout of ECM and/or increased
permeability of the thin sclera.23,35 Future investigations may
unravel further details of the processes involved in IOP and
ASP elevation.
The intersegment variability in the OF changes and ASP in
response to cochlin expression also suggests that differences in
cochlin levels within the tissue and in cochlin–protein inter-
actions in different TM segments play a role. We identified
annexin A2 as a molecule that may interact with cochlin in the
glaucomatous TM.15 Annexin A2 is a membrane binding pro-
tein that has been implicated to play a role in exocytosis.36
However, not all functions of annexin A2 are known and its
role in the TM remains unclear. The role of annexin A2 in
dynamic remodeling of the cytoskeleton,37 may be linked to
the cochlin-annexin A2 interaction in the TM. The presence of
cochlin may also contribute to collagen degradation,9 leading
to alteration of TM ECM and consequently to modulation of OF.
However, at present there is no direct evidence that cochlin
expression affects collagen degradation in vivo.
The observed effect of cochlin is not explicable simply due
to overexpression of cochlin causing clogging of the TM. In
biological systems, more than a 15% variation in total protein
expression under only slightly different conditions (for exam-
ple, circadian fluctuations) is not uncommon, and it is unlikely
that overexpression of a single protein would exceed the same
level of the natural variation in total protein expression. Per-
fusion experiments performed using human organ culture an-
terior segments (HOCASs) with BSA and myocilin also suggest
that expression of a single protein alone does not always lead
to blockage of the outflow pathway. Expression of myocilin
alone, even at a much higher protein level of 25 g/mL, was
insufficient to decrease OF in HOCAS unless aqueous humor
was also present.38,39
The present study also suggests that COCH gene delivery to
the TM may be used to develop a glaucoma model in vivo.
However, it is not known whether transient cochlin expres-
sion in the TM and secretion into the aqueous humor is suffi-
cient to maintain permanent changes in OF and IOP. If pro-
longed cochlin expression is necessary to maintain IOP
elevation and OF reduction in vivo, transgene delivery by
lentivectors (Buie LK, et al. IOVS 2007;48:ARVO E-Abstract
2050)40 and scAAV vectors33 should be considered, since ad-
enoviruses, such as those used in the present study, provide
only transient gene delivery.41,42 Further investigations are
needed to elucidate the biology of the cochlin effect on OF and
IOP and perhaps reveal approaches that may be developed for
glaucoma therapy.
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